Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Quattro74on Aug 12, 2020 3:45pm
259 Views
Post# 31399830

RE:RE:RE:RE:RE:RE:Phase II Resumes, Upbeat NR

RE:RE:RE:RE:RE:RE:Phase II Resumes, Upbeat NR
busterbrown27 wrote:
I wouldn't say we lost a year. We lost 5 months...But because of that delay we learned about the under treatments. The delay was a blessing in disguise IMO. What if they had under treated more patients?... Only thing I'm worried about is having enough funds left in the bank to finish out this trial. Should have a better idea end of the year


Yeah, I worry about funds too, maybe the AGM will gives us that data. Let's call it 8 months lost, when looking at how they're calculating durable CR. So notta whole year, ;-) I guess a bright side. Yes, very true that without the Covid delay they might of forged ahead with a flawed study, maybe a lucky break, indeed.

<< Previous
Bullboard Posts
Next >>